Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Indacaterol 27.5 mcg; Drug: Indacaterol 37.5; Drug: Indacaterol 55 mcg; Drug: Indacaterol 75 mcg; Drug: Indacaterol 150 mcg; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified October 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Study seeks help for treating asthma
WWL NEW ORLEANS – In Southeast Louisiana, we have a higher rate of people living with asthma. It could be because of the higher humidity, mold and plant pollen. Medications work well, but some have side effects. Now you can try a new treatment, free, that … |
View full post on asthma – Google News
NY1 |
Study Examines Prevalence Of Asthma In Low-Income Communities – NY1
NY1 A team of researchers are looking even further into the consistent and growing prevalence of asthma in certain low-income communities in the city. Matt Perzanowski and his team of researchers at Columbia University are taking filters of collected dust … |
View full post on asthma – Google News
Examiner.com |
Telemedicine study seeks to aid children with asthma
Examiner.com Today's Democrat & Chronicle highlights an alliance between the University of Rochester Medical Center (URMC) and the Rochester City School District which may improve the treatment of children with asthma. Researchers headed by Dr. Jill Halterman, … |
View full post on asthma – Google News
NY1 |
Asthma Among Top Three Learning "Barriers", Study Finds
NY1 A new study ranks asthma, vision problems, and mental issues as the top three reasons many city children have trouble in school. A study done by the Children's Health Fund study and the principals union also finds hunger and fatigue are also serious … |
View full post on asthma – Google News
|
Study Examines Prevalence Of Asthma In Low-Income Communities
NY1 A team of researchers are looking even further into the consistent and growing prevalence of asthma in certain low-income communities in the city. Matt Perzanowski and his team of researchers at Columbia University are taking filters of collected dust … |
View full post on asthma – Google News
|
In late-stage study, Novartis finds asthma drug effective at reducing itch …
MedCity News ZURICH (Reuters) – Swiss drugmaker Novartis said on Saturday its drug omalizumab was almost doubly effective in improving quality of life for patients with a severe form of hives, compared with a placebo, according to a late-stage study. The third and … |
View full post on asthma – Google News
Swedish researchers have completed a study of the methods of diagnosing asthma. Their findings suggest that administering a combination of the two primary tests used to detect the condition leads to a better diagnosis and more appropriate treatment.
View full post on Health News Headlines – Yahoo! News
Condition: Rhinoconjunctivitis
Interventions: Biological: ToleroMune HDM; Biological: Placebo
Sponsors: Circassia Limited; Circassia Limited; Adiga Life Sciences
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Non-Smokers With History of Asthma Sought for Medical Study
The Ledger If CPAP, which stands for continued positive airway pressure, improves asthma by relaxing airways, that could mean less need for inhalers and use of inhaled rescue medications. USF is one of 18 centers in the American Lung Association Asthma Clinical … |
View full post on asthma – Google News